Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
about
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsDiagnosis of Irritable Bowel Syndrome: Role of Potential BiomarkersEarly response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatmentSystematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers.Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.No increase in prevalence of somatization in functional vs organic dyspepsia: a cross-sectional survey.The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.Alterations in serotonin metabolism in the irritable bowel syndrome.Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation?Editorial: latent class analysis to improve confidence in the diagnosis of IBS.Editorial: challenging established perceptions of brain-gut interactions in functional gastrointestinal disorders - brain-gut, gut-brain, or both?Defining the functional gastrointestinal disorders is challenging: are clinical symptoms alone sufficient?Irritable Bowel Syndrome.Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
P2860
Q26748617-2E8C0C9C-EB34-4316-8DD5-AF3CD8883B4EQ26823844-856458A3-F7BD-44D2-8E07-B642C7E55895Q33628494-91A77A08-7428-4E4D-BC09-0782FA9A2807Q35825753-F4C78247-B914-4A7B-A3B0-C5879E8EA90AQ38528017-29A4A882-D215-4AF7-93D3-E6FADA362C7AQ39010841-C4EE297A-1DBD-4D5A-BC42-C0F0509DAF11Q39535724-83EEAFD5-A0A2-4568-925C-A952BF5B869FQ40910682-494BD4A3-81CB-4D7C-B908-D2AEC26B7275Q40990248-E3FC3F53-134E-4B4B-878C-0891C9666633Q47574638-36ECD191-350C-4A3A-A0D2-05074F2FD5C3Q47920570-E46777B7-3F53-470F-BAFF-8B987F4BEB71Q48112798-D79D652C-2173-4E3D-8BCF-23A8DFD5CF70Q48334612-D961CD4B-A128-4ED3-A465-EAA7403E05F8Q48510513-AEAC026C-94FD-4797-8931-9D047CAA40D9Q49612276-07069D76-2960-4E69-AC48-CEC24F4EAF0AQ50861627-4FA91D67-2B20-4BD8-A9E3-7665D2321F89Q51318765-F0399F59-B772-4BD2-B3E7-46419C3C19F1
P2860
Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@ast
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@en
type
label
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@ast
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@en
prefLabel
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@ast
Irritable bowel syndrome is si ...... nts, which may drive bloating.
@en
P2093
P2860
P356
P6366
P1154
2-s2.0-84921884584
P1476
Irritable bowel syndrome is si ...... ents, which may drive bloating
@en
P2093
P2860
P304
P356
10.1111/APT.13074
P407
P5530
P577
2015-01-14T00:00:00Z
P5875
P6179
1040584413
P6366
2033219095